UNI-EN 11:Closed proceedings against Krka Romania S.R.L.
Firma: KRKA, TOVARNA ZDRAVIL D.D.Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 11 | / | 2022 | |||||||
| Date of issue: | 2022-06-03 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Closed proceedings against Krka Romania S.R.L. | |||||||||||
| Official market - legal basis | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| According to the provisions of the Ljubljana Stock Exchange Rules and the applicable legislation, Krka, d. d., Novo mesto publishes as follows: We hereby inform the interested public that the Romanian Anti-Corruption Directorate (Direcția Națională Anticorupție, DNA) has concluded the investigation of the alleged irregularities in conducting operations at Krka’s subsidiary, Krka Romania S.R.L. Krka reported on alleged irregularities in its Romanian subsidiary in a public announcement of 17 January 2020, after the Romanian news portal the Libertatea was the first to publish about alleged irregularities. Following the news release, the Romanian DNA launched ex officio investigation of the alleged irregularities at Krka Romania S.R.L. The investigation revealed that all promotional activities carried out by Krka Romania S.R.L. complied with the applicable legislation and good practice guidelines governing promotion of medicinal products in the EU and Romania. The DNA established no substantiated grounds for a suspected criminal offence by Krka Romania S.R.L. or its employees in marketing of medicinal products in Romania. DNA consequently closed the proceeding against Krka Romania S.R.L. Krka has no knowledge of any appeal being lodged within the appeal term against the resolution passed by the DNA. This notice is publicly available at the corporate web site www.krka.si from 3 June 2022 for the period of at least five (5) years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2022-06-03 | Jože Colarič | President of the Management Board and CEO | |||
Cena akcji Krka
Cena akcji Krka w momencie publikacji komunikatu to 416.0 PLN. Sprawdź ile kosztuje akcja Krka aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Krka.
